Technology News and Research

RSS

MabCure retains CUNY CAT to evaluate monoclonal antibodies against ovarian cancer

MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.

29 Mar 2012

Greenway announces availability of PrimeMOBILE

Greenway Medical Technologies, Inc. today announced the availability of its remote clinical and financial solution PrimeMOBILE as a native application for download onto Android smartphone and tablet devices.

29 Mar 2012

Meditation decreases depression, anxiety and stress in school teachers

Schoolteachers who underwent a short but intensive program of meditation were less depressed, anxious or stressed - and more compassionate and aware of others' feelings, according to a UCSF-led study that blended ancient meditation practices with the most current scientific methods for regulating emotions.

29 Mar 2012

MESO-1 device can help in diagnosis and treatment of cancer

A new device designed to more effectively produce DNA samples for genetic testing from slide-mounted tissue samples is better equipped than most models on the market to help in the diagnosis and treatment of cancer.

29 Mar 2012

Spherix 2011 net loss decreases to $3.5 million

Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today reported financial results for the year ended December 31, 2011, and recent and upcoming business highlights.

29 Mar 2012

Relievant Medsystems secures $30M in Series D equity financing

Relievant Medsystems, Inc., a privately held medical device company pioneering the therapeutic use of basivertebral nerve ablation for the treatment of chronic axial low back pain, announced today that it has secured $30 million in a Series D equity financing to advance and expand the Company's worldwide clinical development programs.

29 Mar 2012

Luna to extend development and supply agreement with Intuitive Surgical

Luna Innovations Incorporated announced today that it will be extending its development work through 2012 under its development and supply agreement with Intuitive Surgical, Inc., as they work towards the integration of Luna's shape and position sensing technology into Intuitive's medical robotic products.

29 Mar 2012

iSonea launches post-market study of WheezoMeter device for pediatric asthma

Medical technology company, iSonea Ltd. today announced the launch of a post-market study using iSonea's WheezoMeter monitoring technology.

29 Mar 2012

International Isotopes 2011 revenue increases 55% to $9,462,012

International Isotopes Inc. announces the financial results for fiscal year ended December 31, 2011, and plans for a shareholder conference call to review these results and provide a general update on the business performance and plans of the Company in 2012.

29 Mar 2012

Henry Schein launches Dentrix G5 practice management system

Henry Schein Inc., the largest provider of health care products and services to dental, medical and animal health office-based practitioners, today announced the launch of Dentrix G5, a new version of the Dentrix practice management system.

29 Mar 2012

LivHOME introduces LivIndependa for older adults

LivHOME, Inc., one of the nation's largest providers of professionally led at-home care for seniors, today announced the launch of LivIndependa, a tablet-computer based remote care service for older adults.

29 Mar 2012

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Allergan, Inc. today announced that two Phase III clinical trials of BOTOX (onabotulinumtoxinA) as a potential treatment option for patients with idiopathic overactive bladder met their pre-specified primary endpoints.

29 Mar 2012

EU-funded project to help control appetite, combat obesity

The University of Liverpool is leading a £6milllion European project to develop and test new food products with satiating qualities to help control appetite, manage weight and combat obesity.

29 Mar 2012

Potential new therapy that kills cancer cells selectively

Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.

28 Mar 2012

E-Readers motivates boys, while girls prefer actual books

Middle school boys rated reading more valuable as an activity after two months of using an e-reader, according to a new study.

28 Mar 2012

Incentives encourage behaviors detrimental to good science

The recent explosion in the number of retractions in scientific journals is just the tip of the iceberg and a symptom of a greater dysfunction that has been evolving the world of biomedical research say the editors-in-chief of two prominent journals in a presentation before a committee of the National Academy of Sciences (NAS) today.

28 Mar 2012